| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年5月 |
Exoskeleton Market – Global Forecast To 2030
本調査レポートは、エクソスケルトン（外骨格）市場をコンポーネント（ハードウェア、ソフトウェア）、タイプ（電動、受動、ハイブリッド）、部位（下肢、上肢、全身）、構造（リジッド、ソフト）、モビリティ（固定、モバイル）、垂直（医療、防衛、産業、建設、その他の垂直）、地域（北米、欧州、アジア太平洋、その他の地域）別に分類しています。レポートは、外骨格市場の成長に影響を与える推進要因、制約、課題、機会など、主要な要因に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、事業概要、ソリューション、サービス、主要戦略（契約、パートナーシップ、合意、新製品発売、合併・買収）、そして外骨格市場に関連する最近の動向に関する洞察を提供しています。本レポートは、外骨格市場エコシステムにおける新興企業の競合分析も網羅しています。
The exoskeleton market is estimated to be USD 0.56 billion in 2025 and is projected to reach USD 2.03 billion by 2030, registering a CAGR of 29.4% during the forecast period.
エクソスケルトン（外骨格）市場は2025年には5億6,000万米ドルに達すると推定され、2030年までに20億3,000万米ドルに達すると予測されており、予測期間中に29.4%のCAGRを記録します。
Exoskeletons are important for improving mobility for people with physical impairment and reducing physical strain for industrial workers, leading to the integration of exoskeletons in healthcare and manufacturing. As the elderly population increases and patients at home for rehabilitation become more prevalent, the need for exoskeletons will only rise. As more technologies become available (AI, sensors, lightweight materials), exoskeleton products will function better, cheaper, and be more available. The process of product development and the growth of the exoskeleton market internationally will only be improved by continued investments by both the public and private sectors.
エクソスケルトンは、身体に障がいのある人々の移動能力の向上や産業従事者の身体的負担軽減に重要であり、医療や製造業への統合が進んでいます。高齢者人口の増加や在宅リハビリテーション患者の増加に伴い、外骨格のニーズはますます高まっていくでしょう。AI、センサー、軽量素材といった技術の進歩に伴い、外骨格製品はより高性能で、より安価になり、より入手しやすくなります。製品開発プロセスの改善と国際的な外骨格市場の成長は、官民双方による継続的な投資によってのみ実現できるでしょう。
Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), and Levitate Technologies, Inc. (US) are some of the key players in the exoskeleton market.
The report provides insights on the following pointers:
- Analysis of key drivers (Rising demand for robotic rehabilitation solutions from healthcare sector, Increased adoption in industrial and manufacturing sectors, Increased FDA approvals for medical exoskeletons), restraints (High cost of ownership), opportunities (Integration of exoskeletons with AI and IoT technologies, Increasing adoption of exoskeletons in military and defense sector), and challenges (Comfort and movement interference for workers, Power supply limitations and operational downtime) influencing the growth of the exoskeleton market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the exoskeleton market
- Market Development: Comprehensive information about lucrative markets – the report analyses the exoskeleton market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the exoskeleton market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), Levitate Technologies, Inc. (US), among others in the exoskeleton market.